Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05196646
Other study ID # 2022-7444
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 5, 2022
Est. completion date July 30, 2024

Study information

Verified date September 2023
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact Wissam M Shalish, MD PhD
Phone 514-412-4400
Email wissam.shalish@mcgill.ca
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is an observational, proof-of-concept, feasibility study where 50 preterm infants with gestational age < 32+0 weeks will be recruited from the neonatal intensive care unit (NICU) at the Montreal Children's Hospital. The study's primary objective is to describe the relationship between respiratory acoustics and airflow and determine the reliability of a novel respiratory acoustic sensor at detecting breathing sounds in preterm infants. The study's secondary objectives are: 1. To compare transthoracic impedance, respiratory inductive plethysmography and an inertial measurement unit for the detection of respiratory efforts in preterm infants. 2. To evaluate the feasibility and accuracy of a novel, non-invasive method for continuously detecting and differentiating cardiorespiratory events in preterm infants on CPAP by integrating measurements of respiratory effort with respiratory acoustic monitoring.


Description:

Cardiorespiratory events, defined by the occurrence of apneas, bradycardias, and desaturations, are almost ubiquitous in very preterm infants and are associated with numerous complications. Unfortunately, the current standard for monitoring cardiorespiratory events in the NICU, transthoracic impedance (TTI), does not permit for accurate differentiation of the different types of cardiorespiratory events; TTI cannot detect airflow and has low accuracy for detecting respiratory efforts. As a result, TTI does not detect obstructive apneas and may not reliably capture all central apneas. Respiratory sounds are an attractive surrogate measure of airflow, and can be captured using respiratory acoustic technology (akin to a miniaturized electronic stethoscope). We hypothesize that respiratory acoustic monitoring can provide a continuous, non-invasive, and accurate representation of airflow and breathing sounds in preterm infants. Altogether, we conjecture that the combination of respiratory acoustic monitoring with measurements of respiratory effort will improve the ability to differentiate and describe the nature of cardiorespiratory events in preterm infants.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date July 30, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 72 Hours and older
Eligibility Inclusion Criteria for all infants: - Gestational age < 32+0 weeks - Postmenstrual age between 28+0 and 36+6 weeks. Additional inclusion criteria for Groups 1 and 2: - Off any respiratory support and breathing in-room air - Less than 3 clinically significant cardiorespiratory events per calendar day Additional inclusion criteria for Group 3: - On the bubble CPAP device with the binasal prongs interface - Receiving CPAP levels of 5 to 7 cm H2O with gas flows not exceeding 10L/min - At least 3 clinically significant cardiorespiratory events per calendar day Exclusion Criteria: - Major known congenital abnormalities - Known congenital heart disorders - Known neuromuscular disease - Known diaphragmatic paralysis or a diagnosed phrenic nerve injury - History of esophageal perforation in the 7 days preceding the study - History of pneumothorax requiring chest tube insertion in the 7 days preceding the study - Receiving inotropes, narcotics, or sedative agents at the time of study recording Additional exclusions at the time of the study recording: - Infants receiving ventilator-derived CPAP - Infants receiving CPAP via a nasal mask interface. - Infants receiving inotropes, narcotics or sedative agents - Infants deemed clinically unstable for the study by the attending neonatologist.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Respiratory Acoustic Sensors
Wireless sensor that contains a dual microphone and an inertial measurement unit (IMU) will capture the breathing sound and respiratory effect. Two wireless sensors will be used, with one placed on the suprasternal notch and the other placed on the right upper chest of the infant, in order to determine the sensor placement yielding the best respiratory signal. Data will be transmitted in real-time to a research-dedicated tablet using the Bluetooth Communication Controller (ISP1807, Insight SIP) and stored on the same device for future analysis.
Nasal thermistor
The nasal temperature probe that detects changes in temperature between inhaled and exhaled gases allows for the surrogate measure of airflow. It will be placed in one naris and secured with tape at the upper lip or cheek. The nasal temperature signal will be acquired using the Power Lab analog-digital acquisition system and stored for later analysis.
Respiratory Inductive Plethysmography
Two respiratory bands will be placed circumferentially around the infant's chest (at the level of nipple line) and around the abdomen (just above the level of the umbilicus) in order to measure chest and abdominal wall movements, respectively. These movements will be recorded using Respiratory Inductive Plethysmography (Respitrace QDC®, Viasys® Healthcare, USA). The Respitrace® signals will be acquired using the Power Lab data acquisition system and stored for later analysis.
Pneumotachometer
The pneumotachometer is a pressure-differential based flow sensor that is used to measure respiratory flow. It will be connected to a standard face mask that is gently applied to cover the infant's mouth and nose. The face mask will be similar to the masks used as part of standard of care in the NICU for infants who require continuous positive pressure, with or without ventilation. The flow measurements will be recorded using the Power Lab data acquisition system and stored for later analysis.

Locations

Country Name City State
Canada McGill University Health Center Montreal Quebec

Sponsors (2)

Lead Sponsor Collaborator
McGill University Health Centre/Research Institute of the McGill University Health Centre Northwestern University

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reliability of respiratory acoustics at detecting airflow compared to airflow measurements obtained from a pneumotachometer. The airflow signal derived from the respiratory acoustic sensor will be compared with the airflow signal derived from the pneumotachometer. 10 minutes (group 1) or 3 hours (groups 2 and 3)
Secondary Reliability of the inertial measurement unit (IMU) at detecting respiratory efforts compared to Respiratory Inductance Plethysmography (RIP). The chest wall movement signal derived from the respiratory acoustic sensor will be compared with the chest wall movement signal derived from RIP. 3 hours (groups 2 and 3 only)
Secondary Reliability of the inertial measurement unit (IMU) at detecting respiratory efforts compared to Transthoracic Impedance (TTI). The chest wall movement signal derived from the respiratory acoustic sensor will be compared with the chest wall movement signal derived from TTI. 3 hours (groups 2 and 3 only)
See also
  Status Clinical Trial Phase
Recruiting NCT03670732 - CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure N/A
Terminated NCT02524249 - Early Versus Late Caffeine for ELBW Newborns N/A
Completed NCT03292562 - A Comparison of Methods of Discontinuing Nasal CPAP in Premature Infants <30 Weeks Gestation N/A
Recruiting NCT05298748 - The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants N/A
Recruiting NCT05968586 - Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants N/A
Active, not recruiting NCT02641249 - Non-invasive Intervention for Apnea of Prematurity N/A
Terminated NCT01911182 - Inhalation of Low Concentration of CO2 in Preterm Infants Not Responding to Caffeine for the Treatment of Apnea Phase 2/Phase 3
Completed NCT00182312 - Caffeine for Apnea of Prematurity (CAP) Phase 3
Recruiting NCT03651648 - Apnea Treatment in Premature Infants Using an Automatic Vibro-tactile Stimulator Triggered by the Detection of Apnea-bradycardia. N/A
Recruiting NCT03298347 - Caffeine for Preterm Infants With Apnea of Prematurity(AOP) N/A
Completed NCT01020357 - Caffeine for Apnea of Prematurity-Sleep (CAP-S) Study Phase 3
Completed NCT00809055 - MRI and Neurodevelopment in Preterm Infants Following Administration of High-Dose Caffeine Phase 4
Completed NCT03298035 - A Comparison of Non-invasive Ventilation Methods Used to Prevent Endotracheal Intubation Due to Apnea in Very Low Birth Weight Infants N/A
Completed NCT03695900 - Arterial Oxygen Saturation on Ventilatory Stability in Extremely Premature Infants N/A
Completed NCT04327466 - Effect of High Frequency Oscillatory Highflow Nasal Cannula on Desaturations and Bradycardia in Preterm Infants N/A
Not yet recruiting NCT06374147 - "Prapela® SVS Incubator Pad for Apnea of Prematurity N/A
Completed NCT04868565 - Target Weaning Oxygen to Determine Cafffeine Duration for AOP Phase 4
Terminated NCT00482040 - Randomized Trial Investigating Four Nasal CPAP Systems in the Management of Apnea of Prematurity N/A
Not yet recruiting NCT06292299 - The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
Completed NCT05393817 - Caffeine Citrate Use and Electronic Activity of the Diaphragm (EDI) Changes